Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Drug Metabolism Reviews
Volume 54, 2022 - Issue 3
Review Articles
Bioactivation and reactivity research advances – 2021 year in review
Klarissa D. Jacksona Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA
https://orcid.org/0000-0002-9388-9800View further author information
https://orcid.org/0000-0002-9388-9800View further author information, Upendra A. Argikarb Non-Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USAhttps://orcid.org/0000-0002-0939-0813View further author information
https://orcid.org/0000-0002-0939-0813View further author information, Sungjoon Choc Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0003-1215-9759View further author information
https://orcid.org/0000-0003-1215-9759View further author information, Rachel D. Crouchd Department of Pharmaceutical Sciences, Lipscomb University College of Pharmacy and Health Sciences, Nashville, TN, USAhttps://orcid.org/0000-0002-4525-6072View further author information
https://orcid.org/0000-0002-4525-6072View further author information, James P. Driscolle Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Brisbane, CA, USAhttps://orcid.org/0000-0002-3736-1673View further author information
https://orcid.org/0000-0002-3736-1673View further author information, Carley J. S. Heckf Medicine Design, Pfizer Worldwide Research, Development and Medical, Groton, CT, USAhttps://orcid.org/0000-0002-6842-3670View further author information
https://orcid.org/0000-0002-6842-3670View further author information, Lloyd Kingg Department of DMPK, UCB Biopharma UK, Slough, UKhttps://orcid.org/0000-0002-3301-7533View further author information
https://orcid.org/0000-0002-3301-7533View further author information, Hlaing (Holly) Mawh Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0002-4051-7958View further author information
https://orcid.org/0000-0002-4051-7958View further author information, Grover P. Milleri Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USAhttps://orcid.org/0000-0002-4743-8187View further author information
https://orcid.org/0000-0002-4743-8187View further author information, Herana Kamal Seneviratnej Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USAhttps://orcid.org/0000-0002-7221-7060View further author information
https://orcid.org/0000-0002-7221-7060View further author information, Shuai Wangc Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-3282-1343View further author information
https://orcid.org/0000-0002-3282-1343View further author information, Cong Weik Drug Metabolism & Pharmacokinetics, Biogen Inc., Cambridge, MA, USAhttps://orcid.org/0000-0003-2310-9255View further author information
https://orcid.org/0000-0003-2310-9255View further author information, Donglu Zhangc Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0001-8677-9737View further author information
https://orcid.org/0000-0001-8677-9737View further author information & S. Cyrus Khojastehc Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-8385-9288View further author information
https://orcid.org/0000-0002-8385-9288View further author information show all